University of Florence, School of Medicine, Florence, Italy.
Postgrad Med. 2010 Jan;122(1):108-17. doi: 10.3810/pgm.2010.01.2104.
Mortality from cardiovascular diseases, such as myocardial infarction (MI), is predicted to increase dramatically in Asia-Pacific countries. However, there are few studies that estimate utilization of prophylactics, such as low-dose aspirin, in these countries. To determine this, an online survey was sent to physicians in 18 countries worldwide, and this article reports the findings from the Asia-Pacific region (N = 4372 respondents). The overall mean number of MI patients per respondent was 246 in the Asia-Pacific countries, and 55% of physicians (overall) rated their patient as having total compliance with aspirin. The use of aspirin monotherapy or combination therapy, aspirin dosage, and physician contact were all found to have a significant impact on compliance (all P < 0.00001). Educational material on the role of aspirin was ranked as the most effective measure to improve compliance. In conclusion, this survey indicates that educational initiatives on secondary prevention are urgently needed in Asia-Pacific countries.
心血管疾病（如心肌梗死，MI）导致的死亡率预计将在亚太国家大幅上升。然而，关于这些国家使用预防药物（如小剂量阿司匹林）的研究甚少。为了了解这一点，我们向全球 18 个国家的医生进行了在线调查，本文报告了亚太地区（N=4372 名受访者）的调查结果。在亚太国家，每位医生平均管理的 MI 患者人数为 246 人，55%的医生（总体而言）认为他们的患者对阿司匹林完全依从。结果发现，阿司匹林单药治疗或联合治疗、阿司匹林剂量和医生联系都对依从性有显著影响（均 P<0.00001）。关于阿司匹林作用的教育资料被列为提高依从性的最有效措施。总之，这项调查表明，亚太国家迫切需要开展关于二级预防的教育计划。
